## Abstract Studies are described on the metabolism and toxicological detection of the phencyclidine‐derived designer drug __N__‐(1‐phenylcyclohexyl)‐3‐ethoxypropanamine (PCEPA) in rat urine using gas chromatographic/mass spectrometric techniques. The identified metabolites indicated that PCEPA was
New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques
✍ Scribed by Christoph Sauer; Frank T. Peters; Roland F. Staack; Giselher Fritschi; Hans H. Maurer
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 359 KB
- Volume
- 43
- Category
- Article
- ISSN
- 1076-5174
- DOI
- 10.1002/jms.1312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Studies are described on the metabolism and the toxicological detection of the phencyclidine‐derived designer drugs N‐(1‐phenylcyclohexyl)‐2‐ethoxyethanamine (PCEEA) and N‐(1‐phenylcyclohexyl)‐2‐methoxyethanamine (PCMEA) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques. The identified metabolites indicated that PCEEA and PCMEA were transformed to the same metabolites by N‐dealkylation and O‐dealkylation partially followed by oxidation of the resulting alcohol to the respective carboxylic acid and hydroxylation of the cyclohexyl ring at different positions and combinations of those. Finally, aromatic hydroxylation of the O‐dealkylated metabolites was partially followed by hydroxylation of the cyclohexyl ring at different positions. All metabolites were partially excreted in conjugated form. The authors' systematic toxicological analysis (STA) procedure using full‐scan GC/MS after acid hydrolysis, liquid–liquid extraction and microwave‐assisted acetylation allowed the detection of an intake of a common drug users' dose both of PCEEA and PCMEA in rat urine. Assuming similar metabolism in humans, the STA should be suitable for proof of an intake of PCEEA and PCMEA in human urine, although their differentiation is not possible due to common metabolites. Copyright © 2007 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract Studies are described on the metabolism and the toxicological detection of the amphetamine‐derived designer drug 2,4,5‐trimethoxyamphetamine (TMA‐2) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques. The identified metabolites indicated that TMA‐2 was metaboli
## Abstract The aim of the present study was to identify the metabolites of the new designer drug α‐pyrrolidinovalerophenone (PVP) in rat urine using GC/MS techniques. Eleven metabolites of PVP could be identified suggesting the following metabolic steps: hydroxylation of the side chain followed by
## Abstract Studies are described on the metabolism and the toxicological analysis of the amphetamine‐derived designer drug 2,5‐dimethoxy‐4‐bromo‐amphetamine (DOB) and its corresponding __N__‐methyl analogue 2,5‐dimethoxy‐4‐bromo‐methamphetamine (MDOB) in rat urine using gas chromatographic/mass sp
## Abstract Studies are described on the metabolism and the toxicological analysis of the phenethylamine‐derived designer drug 4‐iodo‐2,5‐dimethoxy‐β‐phenethylamine (2C‐I) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques, and for a particular question, using capillary el
## Abstract The phenethylamine‐derived designer drug 2,5‐dimethoxy‐4‐methyl‐β‐phenethylamine (2C‐D) was found to be metabolized in rats by __O__‐demethylation at position 2 or 5 followed by __N__‐acetylation or by deamination with oxidation to the corresponding acids or reduction to the correspondi